CVR Medical Logo
CA1266321084
A2ASKP
CRRVF

CVR Medical

Loading quotes...

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

  • CVR Energy misses Q1 2026 forecasts significantly and reports large net loss

    CVR Energy reported Q1 2026 EPS of -1.24 USD, well below the expected -0.38 USD, while revenue of 1.98 billion USD exceeded estimates. The company recorded a consolidated net loss of 160 million USD and adjusted EBITDA of 37 million USD. Results were hurt by unrealized losses on derivative transactions and high RIN prices; the stock fell 1.58% in premarket trading. For Q2 2026 CVR expects throughput of 200,000–215,000 bpd and direct operating costs of 110–120 million USD; strategic adjustments to the crude slate are intended to improve margins. » More on de.investing.com


  • CVR Energy hits 52-week high and offers high dividend yield

    CVR Energy’s stock rose to $33.25, marking a 52-week high and bringing market capitalization to about $3.33 billion. The yield is 11.49% and the company has paid dividends for 12 consecutive years. Despite a strong price gain of 39.4% over the past year (58.45% in six months), CVR reported an adjusted loss per share of $0.23 in Q2/2025 (expectation: -$0.06), but beat revenue expectations with $1.76 billion. Analyst notes indicate the stock may be trading above its fair value; gross profit margin remained weak at 1.63%. » More on de.investing.com


  • CVR Energy reaches 52-week high at 32.67 USD

    CVR Energy’s stock rose to a 52-week high of 32.67 USD and has gained 70.7% over the past six months; year-to-date the increase is 49.4%. InvestingPro cites a dividend yield of 11.35% and notes 12 consecutive years of dividend payments, but considers the stock to be above its fair value. For Q2 2025 the company reported an adjusted loss per share of 0.23 USD (expectation: -0.06 USD) on revenue of 1.76 billion USD (expectation: 1.68 billion USD), after which the stock fell sharply in after-hours trading. » More on de.investing.com


  • CVRx increases revenue but misses earnings forecast in second quarter 2025

    CVRx grew its revenue by 15% to $13.6 million in the second quarter of 2025, surpassing expectations, but reported a higher net loss of $0.57 per share compared to the forecast of $0.52. The stock saw a slight decline as profitability remains a challenge. The company is maintaining its full-year revenue guidance and is focusing on expanding in the US market and strengthening its sales team. » More on de.investing.com


  • CVRx receives continued Medicare reimbursement for Barostim but lowers revenue forecast

    The Centers for Medicare and Medicaid Services propose to continue reimbursing CVRx's Barostim implantation procedure at around $45,000. Despite this positive regulatory development, CVRx missed revenue expectations in the first quarter and lowered its annual forecast, citing sales challenges. Analysts downgraded the stock due to ongoing uncertainties and volatile revenues. » More on de.investing.com

Financials

In the last year, CVR Medical had revenue of €0 and net profit of -€1.58M
(EUR) 2021
YoY
Revenue 0 -
Gross profit -215.45 7.54%
Net profit -1.58M 1,012.76%
EBITDA -602.63K 1,587.74%

Fundamentals

Metric Value
Market capitalization
€976.31
Number of shares
107.2M
52-week high/low
€0.0000091 - €0.0000009
Dividends No
Beta
1.82
P/E ratio
0.00
PEG ratio
0.00
P/B ratio
0.00
P/S ratio
0.00

Company profile

CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.

Name
CVR Medical
CEO
Darren Day
Headquarters North Vancouver, bc
Canada
Website
IPO
11/02/2016
Employees 3

Ticker symbols

Exchange Symbol
Pnk
CRRVF
London
0UMW.L
München
B3BN.MU
🍪

Parqet  uses cookies. Learn more